Thera4Care launch

Announcing the launch of the Thera4Care project - Theranostics Ecosystem For Personalised Care! This public-private initiative aims to revolutionise precision oncology and establish Europe as a global leader in theranostics. 

Theranostics combines diagnostic tests with targeted therapies, enabling personalised treatments. By binding molecules with radioactive isotopes to specific proteins on cancer cells, the disease can be diagnosed and treated with precision. 

Thera4Care brings together academic centres, healthcare providers, SMEs, and industry stakeholders to create a collaborative European ecosystem to support healthcare system readiness for theranostics. We aim to: 

• Strengthen the manufacturing and supply chain of radiotheranostics. 

• Develop advanced cancer models to test these therapies in the lab. 

• Create a framework for phase 1 clinical trials. 

• Enhance clinical outcomes through AI-based imaging and personalized dosing protocols.

Thera4Care is funded by the Innovative Health Initiative Joint Undertaking (IHI JU) under grant agreement No 101172788. The JU receives support from the European Union’s Horizon Europe research and innovation programme and COCIR, EFPIA, EuropaBio, MedTech Europe, Vaccines Europe, Atley Solutions, Curasight, Dosisoft, Minerva Imaging, Perspective Therapeutics, and Terthera.